NNE

Business Context and Reporting Period

Company: Nano Nuclear Energy Inc. (NNE)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended June 30, 2025
Business Overview: An early-stage, pre-revenue nuclear energy company developing advanced microreactors (KRONOS, ZEUS, ODIN, LOKI), fuel processing, fuel transportation, and nuclear consulting services. The company is classified as an Emerging Growth Company and Smaller Reporting Company but expects to lose this status by September 30, 2025, due to a public float exceeding $700 million.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue: Remains at $0; the company is pre-revenue.
• Expenses:
  • General & Administrative (G&A): Increased 131% QoQ (3-month) and 416% YoY (9-month) to $5.3M and $23.5M respectively, driven by personnel costs, professional fees, and significant equity-based compensation ($12.1M in G&A for the 9-month period).
  • Research & Development (R&D): Increased 82% QoQ and 299% YoY to $3.7M and $11.3M respectively, due to microreactor development and equity-based compensation.
• Other Income: Increased significantly to $1.8M (3-month) and $3.8M (9-month) primarily due to interest income on cash balances ($1.5M and $3.5M respectively) and consulting services ($250k).
• Balance Sheet: Cash increased from $28.5M (Sept 30, 2024) to $210.2M (June 30, 2025) following multiple equity offerings. Total assets grew from $35.1M to $231.5M, largely due to cash and the acquisition of In-Process Research and Development (IPR&D) assets valued at $9.1M.
• Contingent Consideration: Revaluation expense of $401,500 (3-month) and $1,004,000 (9-month) related to the ALIP technology acquisition.

Guidance, Outlook, Risks, and Unusual Items

Management Commentary and Outlook

• Capital Position: Management believes existing cash ($210M) is sufficient to fund operations for at least the next 12 months. Estimated expenditures for the next 12 months are approximately $40M.
• Strategic Milestones:
  • KRONOS MMR: Collaborating with UIUC to construct a research reactor; anticipates submitting a construction permit application to the NRC by late 2025/early 2026.
  • ODIN: Considering strategic alternatives to monetize the project to focus resources on KRONOS.
  • Fuel Supply: Selected by the DOE as a subcontractor in the LEU Enrichment Acquisition Program alongside related party LIST.
• Future Financing: Filed a universal shelf registration statement in July 2025 to raise up to $620 million, including a $400 million "at-the-market" program.

Risks and Contingencies

• Going Concern: While currently liquid, the company has an accumulated deficit of $49.5M and expects to incur significant losses until commercialization (estimated early 2030s).
• Internal Controls: Identified a material weakness in internal control over financial reporting related to ineffective general IT controls for cloud-based systems. No misstatements were found, but remediation is underway.
• Legal Proceedings:
  • Securities Class Action: Yang v. Nano Nuclear Energy Inc. (S.D.N.Y.) regarding statements on business progress. Motion to dismiss filed; hearing pending.
  • Shareholder Derivative: Latza v. Walker (Nevada). Court granted motions to dismiss; formal decision pending.
• Regulatory: Success depends on obtaining NRC and other regulatory approvals, which are complex and time-consuming.

Unusual Items

• USNC Asset Acquisition: Acquired KRONOS and LOKI assets from Ultra Safe Nuclear Corp. for $8.5M cash (closed Jan 2025). Recorded $9.1M in IPR&D assets.
• Equity Issuances: Raised approximately $191M in net proceeds from October 2024, November 2024, and May 2025 offerings.
• Related Party Transactions: $2M investment in LIST (laser enrichment); lease of Oak Ridge facility space to LIST.

Investor Verification Checklist

• Cash Burn Rate: Verify the sustainability of the $210M cash balance against the projected $40M annual spend and potential for higher-than-expected R&D costs.
• Regulatory Timeline: Assess the feasibility of the late 2025/early 2026 NRC construction permit application for KRONOS, given the complexity of nuclear licensing.
• Internal Control Remediation: Monitor the company's progress in fixing the material weakness in IT controls to avoid future restatements or compliance issues.
• ODIN Strategy: Confirm the outcome of the "strategic alternatives" for the ODIN reactor project and potential monetization value.
• Legal Exposure: Track the status of the securities class action and derivative lawsuit to estimate potential legal costs or settlements.
• Canadian Assets: Verify the status of the $250k escrow and the "Canadian Consents" required to finalize the USNC asset acquisition.